Аспира вуменс хелс что это
About Us
Aspira Women’s Health is dedicated to the discovery, development and utilization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women.
What We Do
We are helping to transform women’s health with the discovery, development, and utilization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. Our FDA-cleared products OVA1 ® and OVERA ® detect the risk of ovarian malignancy in women with adnexal masses. Recently launched, Aspira GenetiX SM testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of experience in ovarian cancer risk assessment, Aspira Women’s Health has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans.
Our Vision
Our Vision is TO HELP GLOBALLY TRANSFORM WOMEN’S HEALTH, starting with OVARIAN CANCER, and improve survival and life through our innovative health solutions. Our end goal is “BETTER HEALTH AND WELL BEING” for patients and the people that serve them. One patient is five lives transformed.
You can trust the results that Aspira Women’s Health provides and take comfort in the knowledge that OVA1 testing is FDA cleared and we are certified by Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP), which means that we adhere to the highest standards in the clinical laboratory industry. We pride ourselves on being very influential in women’s healthcare and ovarian cancer risk diagnosis.
We have a passion for assisting health care providers in the delivery of relevant and timely care to women. We believe our passion will become evident to you in the level of service that we provide.